| Silkworm pathogenic bacteria infection model for identification of novel virulence genes C Kaito, K Kurokawa, Y Matsumoto, Y Terao, S Kawabata, S Hamada, ... Molecular microbiology 56 (4), 934-944, 2005 | 199 | 2005 |
| Novel DNA binding protein SarZ contributes to virulence in Staphylococcus aureus C Kaito, D Morishita, Y Matsumoto, K Kurokawa, K Sekimizu Molecular microbiology 62 (6), 1601-1617, 2006 | 118 | 2006 |
| An invertebrate hyperglycemic model for the identification of anti-diabetic drugs Y Matsumoto, E Sumiya, T Sugita, K Sekimizu PloS one 6 (3), e18292, 2011 | 113 | 2011 |
| Intestinal resident yeast Candida glabrata requires Cyb2p-mediated lactate assimilation to adapt in mouse intestine K Ueno, Y Matsumoto, J Uno, K Sasamoto, K Sekimizu, Y Kinjo, ... PloS one 6 (9), e24759, 2011 | 108 | 2011 |
| S, Sumida, N, Hagihara H Yamazaki, T Nishid, Y Matsumoto J. Organomet. Chem 6, 86, 1966 | 107 | 1966 |
| Expression profiling of genes related to asthma exacerbations T Aoki, Y Matsumoto, K Hirata, K Ochiai, M Okada, K Ichikawa, ... Clinical & Experimental Allergy 39 (2), 213-221, 2009 | 89 | 2009 |
| Evaluation of Staphylococcus aureus virulence factors using a silkworm model S Miyazaki, Y Matsumoto, K Sekimizu, C Kaito FEMS microbiology letters 326 (2), 116-124, 2012 | 80 | 2012 |
| Quantitative evaluation of cryptococcal pathogenesis and antifungal drugs using a silkworm infection model with Cryptococcus neoformans Y Matsumoto, S Miyazaki, DH Fukunaga, K Shimizu, S Kawamoto, ... Journal of applied microbiology 112 (1), 138-146, 2012 | 75 | 2012 |
| Silkworm as an experimental animal for research on fungal infections Y Matsumoto, K Sekimizu Microbiology and immunology 63 (2), 41-50, 2019 | 56 | 2019 |
| A Novel Gene, fudoh, in the SCCmec Region Suppresses the Colony Spreading Ability and Virulence of Staphylococcus aureus C Kaito, Y Omae, Y Matsumoto, M Nagata, H Yamaguchi, T Aoto, T Ito, ... PLoS One 3 (12), e3921, 2008 | 56 | 2008 |
| Use of silkworm larvae to study pathogenic bacterial toxins MS Hossain, H Hamamoto, Y Matsumoto, IM Razanajatovo, J Larranaga, ... Journal of biochemistry 140 (3), 439-444, 2006 | 54 | 2006 |
| Flat separation membrane leaf and rotary separation apparatus containing flat membranes K Ishii, Y Matsumoto US Patent 5,275,725, 1994 | 50 | 1994 |
| Regulation of Exoprotein Gene Expression by the Staphylococcus aureus cvfB Gene Y Matsumoto, C Kaito, D Morishita, K Kurokawa, K Sekimizu Infection and immunity 75 (4), 1964-1972, 2007 | 47 | 2007 |
| Diabetic silkworms for evaluation of therapeutically effective drugs against type II diabetes Y Matsumoto, M Ishii, Y Hayashi, S Miyazaki, T Sugita, E Sumiya, ... Scientific reports 5 (1), 10722, 2015 | 42 | 2015 |
| Current use of silkworm larvae (Bombyx mori) as an animal model in pharmaco-medical research DD Nwibo, H Hamamoto, Y Matsumoto, C Kaito, K Sekimizu Drug discoveries & therapeutics 9 (2), 133-135, 2015 | 36 | 2015 |
| An invertebrate infection model for evaluating anti-fungal agents against dermatophytosis M Ishii, Y Matsumoto, T Yamada, S Abe, K Sekimizu Scientific Reports 7 (1), 12289, 2017 | 32 | 2017 |
| Acute oral toxicity test of chemical compounds in silkworms K Usui, S Nishida, T Sugita, T Ueki, Y Matsumoto, H Okumura, K Sekimizu Drug discoveries & therapeutics 10 (1), 57-61, 2016 | 32 | 2016 |
| Evaluation of drug-induced tissue injury by measuring alanine aminotransferase (ALT) activity in silkworm hemolymph Y Inagaki, Y Matsumoto, K Kataoka, N Matsuhashi, K Sekimizu BMC Pharmacology and Toxicology 13, 1-7, 2012 | 31 | 2012 |
| Enterococcus faecalis YM0831 suppresses sucrose-induced hyperglycemia in a silkworm model and in humans Y Matsumoto, M Ishii, S Hasegawa, K Sekimizu Communications Biology 2 (1), 157, 2019 | 29 | 2019 |
| Phenotypic and genomic comparisons of highly vancomycin-resistant Staphylococcus aureus strains developed from multiple clinical MRSA strains by in vitro mutagenesis K Ishii, F Tabuchi, M Matsuo, K Tatsuno, T Sato, M Okazaki, H Hamamoto, ... Scientific reports 5 (1), 17092, 2015 | 28 | 2015 |
